Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey Read more about Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey
ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference Read more about ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research Read more about ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research
ICON Announces Appointment of Chief Operating Officer Read more about ICON Announces Appointment of Chief Operating Officer
ICON Survey Highlights Sustained Investment in AI and Digital R&D Innovation, Tempered by Siloed Adoption Read more about ICON Survey Highlights Sustained Investment in AI and Digital R&D Innovation, Tempered by Siloed Adoption
ICON plc to Present at the Jefferies London Healthcare Conference Read more about ICON plc to Present at the Jefferies London Healthcare Conference
ICON plc Schedules Third Quarter 2024 Earnings Conference Call Read more about ICON plc Schedules Third Quarter 2024 Earnings Conference Call
ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape Read more about ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape
